Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing
Also known as: MYE CNV
Use
This test is used to assess somatic sequence variants, copy number variants (CNVs), and copy number-neutral loss of heterozygosity (CN-LOH) with prognostic and/or therapeutic significance in conditions such as acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), and MDS/MPN overlap disorders such as chronic myelomonocytic leukemia (CMML). It aids in the subclassification of myeloid neoplasms and is recommended for initial diagnostic workup and therapeutic monitoring, in accordance with the most updated guidelines. For detecting sequence variants without CNVs and CN-LOH in specific clinical scenarios, a different panel is recommended.
Special Instructions
Specimen source is required for testing, and separate specimens must be submitted when multiple tests are ordered. Sample stability is crucial with whole blood or bone marrow samples remaining stable for up to 72 hours at ambient temperature and 1 week when refrigerated, but they are unacceptable if frozen.
Limitations
Variants outside targeted regions or below detection limits are not identified. Some exons are not covered for certain genes, and technical limitations may exist due to pseudogenes or repetitive/homologous regions. Insertions/deletions may not be detected at LOD. RNA variants, gene fusions, translocations, and large structural variants are not detected. Due to analytical complexities, CNVs may not be reported in cases like stem cell transplants with mixed chimerism, increased genomic complexity, or complex aneuploidies. Also, germline variants and certain CNLOH types are not reported.
Methodology
NGS (Targeted)
Biomarkers
LOINC Codes
- 29548-5
- 31208-2
- 101397-8
- 11502-2
Result Turnaround Time
12-14 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
3 mL
Minimum Volume
1.5 mL
Container
Lavender (EDTA) or green (sodium heparin) tube
Storage Instructions
Refrigerated
Causes for Rejection
Serum, plasma, grossly hemolyzed specimens, buccal brush or swab, FFPE tissue
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 72 hours |
| Refrigerated | 1 week |
| Frozen | Unacceptable |
